<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36740820</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1941-5923</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><PubDate><Year>2023</Year><Month>Feb</Month><Day>06</Day></PubDate></JournalIssue><Title>The American journal of case reports</Title><ISOAbbreviation>Am J Case Rep</ISOAbbreviation></Journal><ArticleTitle>Mitral Valve Replacement for Enlarged Libman-Sacks Endocarditis in a Patient with Persistent Primary Antiphospholipid Syndrome and Recurrent Stroke: A Case Report.</ArticleTitle><Pagination><StartPage>e938930</StartPage><MedlinePgn>e938930</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.12659/AJCR.938930</ELocationID><Abstract><AbstractText>BACKGROUND Anticardiolipin antibodies in patients with Libman-Sacks endocarditis (LS) are indicative of comorbid antiphospholipid syndrome (APS) and can result in cerebral infarctions. We describe a case of LS and primary APS with recurrent cerebral infarctions despite anticoagulation treatment. The patient underwent surgery for enlarged LS vegetation with high titers of antiphospholipid antibodies. CASE REPORT A 41-year-old Japanese man was admitted to hospital for small cerebral infarction recurrence in a left parietal lesion. At age 35, the patient had suffered multiple cerebral infarctions. He was found to have high serum titers of all 3 antiphospholipid antibodies. Transesophageal echocardiography (TEE) findings were normal. Differential diagnosis ruled out other autoimmune diseases and a clinical diagnosis of primary APS was made. Warfarin anticoagulation was started. When cerebral infarction recurred 6 years after the first episode, serum titers of antiphospholipid antibodies remained high, and TEE showed a 7&#xd7;8 mm area of mitral vegetation. A TEE results from his first admission revealed a 5&#xd7;6 mm area of mitral vegetation, which was believed to be related to the current vegetation. As anticoagulation produced no improvement, the mitral valve was replaced with a mechanical valve. Examination of the excised vegetation found it to be consistent with LS. The patient made good progress within 3 years after surgery. CONCLUSIONS LS size can increase despite anticoagulation in cases with high titers of all 3 antiphospholipid antibodies and cerebral infarction. Such patients require ongoing TEE follow-up and surgical treatment should be considered.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takeuchi</LastName><ForeName>Katsuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumi</LastName><ForeName>Tesseki</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nanaura</LastName><ForeName>Hitoki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamada</LastName><ForeName>Nanami</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayata</LastName><ForeName>Yoshihiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Thoracic and Cardiovascular Surgery, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Obayashi</LastName><ForeName>Chiho</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Diagnostic Pathology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sugie</LastName><ForeName>Kazuma</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Nara Medical University, Kashihara, Nara, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Case Rep</MedlineTA><NlmUniqueID>101489566</NlmUniqueID><ISSNLinking>1941-5923</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017152">Antibodies, Antiphospholipid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008943" MajorTopicYN="N">Mitral Valve</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016736" MajorTopicYN="Y">Antiphospholipid Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004696" MajorTopicYN="Y">Endocarditis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017152" MajorTopicYN="N">Antibodies, Antiphospholipid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002544" MajorTopicYN="N">Cerebral Infarction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflict of interest:</b> None declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>6</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36740820</ArticleId><ArticleId IdType="pmc">PMC9909611</ArticleId><ArticleId IdType="doi">10.12659/AJCR.938930</ArticleId><ArticleId IdType="pii">938930</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moyssakis I, Tektonidou MG, Vasilliou VA, et al. Libman-Sacks endocarditis in systemic lupus erythematosus: Prevalence, associations, and evolution. Am J Med. 2007;120:636&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">17602939</ArticleId></ArticleIdList></Reference><Reference><Citation>Roldan CA, Sibbitt WL, Jr, Qualls CR, et al. Libman-Sacks endocarditis and embolic cerebrovascular disease. JACC Cardiovasc Imaging. 2013;6:973&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3941465</ArticleId><ArticleId IdType="pubmed">24029368</ArticleId></ArticleIdList></Reference><Reference><Citation>Turiel M, Sarzi-Puttini P, Peretti R, et al. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol. 2005;96:574&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">16098314</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost. 2006;4:295&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">16420554</ArticleId></ArticleIdList></Reference><Reference><Citation>Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: Prevalence, clinical features, and treatment. Semin Arthritis Rheum. 1997;27:27&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">9287387</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsumi T, Koike T. Cardiac valve diseases and antiphospholipid syndrome. Intern Med. 2000;39:446&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">10852159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramham K, Thomas M, Nelson-Piercy C, et al. First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss. Blood. 2011;117(25):6948&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">21527518</ArticleId></ArticleIdList></Reference><Reference><Citation>Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med. 1924;33:701&#x2013;7.</Citation></Reference><Reference><Citation>Lee JL, Naguwa SM, Cheema GS, Gershwin ME. Revisiting Libman-Sacks endocarditis: A historical review and update. Clin Rev Allergy Immunol. 2009;36:126&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">19089657</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross L. The cardiac lesions in Libman-Sacks disease: With a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol. 1940;16:375&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1965099</ArticleId><ArticleId IdType="pubmed">19970511</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Alton JG, Preston DN, Bormanis J, et al. Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis. Stroke. 1985;16:512&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">4002268</ArticleId></ArticleIdList></Reference><Reference><Citation>Khamashta MA, Cervera R, Asherson RA, et al. Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus. Lancet. 1990;335:1541&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">1972484</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihoyannopoulos P, Gomez PM, Joshi J, et al. Cardiac abnormalities in systemic lupus erythematosus. Association with raised anticardiolipin antibodies. Circulation. 1990;82:369&#x2013;75.</Citation><ArticleIdList><ArticleId IdType="pubmed">2372888</ArticleId></ArticleIdList></Reference><Reference><Citation>Djokovic A, Stojanovich L, Stanisavljevic N, et al. Relationship between cerebrovascular and valvular manifestations in a Serbian cohort of patients with antiphospholipid syndrome. Clin Exp Rheumatol. 2018;36:850&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">29846156</ArticleId></ArticleIdList></Reference><Reference><Citation>Roldan CA, Shively BK, Lau CC, et al. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992;20:1127&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">1341885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziporen L, Goldberg I, Arad M, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: Immunopathologic findings in deformed heart valves. Lupus. 1996;5:196&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pubmed">8803890</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye T, Wang J, Liao S. Mitral valve repair for isolated Libman-Sacks endocarditis in a patient with primary antiphospholipid syndrome. Int Heart J. 2021;62:181&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">33518657</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">8608627</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouma W, Klinkenberg TJ, van der Horst IC, et al. Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: A report of four cases and a systematic review of the literature. J Cardiothorac Surg. 2010;5:13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2859362</ArticleId><ArticleId IdType="pubmed">20331896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tektonidou MG, Andreoli L, Limper M, et al. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019;78:1296&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">31092409</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen AY, Yao JF, Brar SS, et al. Racial/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. J Am Coll Cardiol. 2007;50:309&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">17659197</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia D, Erkan D. Diagnosis and management of the antiphospholipid syndrome. N Engl J Med. 2018;378:2010&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">29791828</ArticleId></ArticleIdList></Reference><Reference><Citation>Panichpisal K, Rozner E, Levine SR. The management of stroke in antiphospholipid syndrome. Curr Rheumatol Rep. 2012;14:99&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pubmed">22109663</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussain H, Tarantino MD, Chaturvedi S, et al. Eculizumab for refractory thrombosis in antiphospholipid syndrome. Blood Adv. 2022;6:1271&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864643</ArticleId><ArticleId IdType="pubmed">35051999</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinstein AA, Giovanelli C, Romano JG, et al. Surgical treatment of nonbacterial thrombotic endocarditis presenting with stroke. J Neurol. 2005;252:352&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">15726268</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhlaq A, Ali TA, Fatimi SH. Mitral valve replacement in systemic lupus erythematosus associated Libman-Sacks endocarditis. J Saudi Heart Assoc. 2016;28:124&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4803760</ArticleId><ArticleId IdType="pubmed">27053904</ArticleId></ArticleIdList></Reference><Reference><Citation>Colli A, Mestres CA, Espinosa G, et al. Heart valve surgery in patients with the antiphospholipid syndrome: Analysis of a series of nine cases. Eur J Cardiothorac Surg. 2010;37:154&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">19699100</ArticleId></ArticleIdList></Reference><Reference><Citation>Brey RL, Chapman J, Levine SR, et al. Stroke and the antiphospholipid syndrome: Consensus meeting Taormina 2002. Lupus. 2003;12:508&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">12892389</ArticleId></ArticleIdList></Reference><Reference><Citation>Turiel M, Muzzupappa S, Gottardi B, et al. Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography. Lupus. 2000;9:406&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">10981643</ArticleId></ArticleIdList></Reference><Reference><Citation>Krawczyk M, Budhram A, Sposato LA. Ischemic stroke from Libman-Sacks endocarditis not associated with antiphospholipid antibodies: Good clinical outcome without anticoagulation. JACC Case Rep. 2019;1:297&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8288987</ArticleId><ArticleId IdType="pubmed">34316811</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>